Company Filing History:
Years Active: 2010
Title: Innovations of Tariq Ghayer in Antibody Development
Introduction
Tariq Ghayer is an accomplished inventor based in Holliston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target interleukin-18 (IL-18). His work has the potential to impact various medical applications, especially in treating disorders associated with IL-18 activity.
Latest Patents
Tariq Ghayer holds a patent for "Antibodies that bind IL-18 and methods of inhibiting IL-18 activity." This patent describes antibodies that specifically bind to human interleukin-18 (hIL-18). The invention includes entirely human antibodies, recombinant antibodies, and monoclonal antibodies. These antibodies are designed to have high affinity for hIL-18 and can neutralize its activity both in vitro and in vivo. The patent also outlines methods for making and using these antibodies, which are useful for detecting hIL-18 and inhibiting its detrimental activity in human subjects.
Career Highlights
Tariq Ghayer is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His role involves research and development in the field of antibody therapeutics. His innovative work has contributed to advancing the understanding and treatment of diseases linked to IL-18.
Collaborations
Tariq has collaborated with notable colleagues, including Richard W. Dixon and Michael Roguska. These collaborations have fostered a productive environment for research and innovation in antibody development.
Conclusion
Tariq Ghayer's contributions to the field of biotechnology, particularly through his patent on antibodies targeting IL-18, showcase his innovative spirit and dedication to improving human health. His work at Abbott Laboratories Corporation continues to pave the way for advancements in medical treatments.